- Home
- MEIP vs TOMZ Comparison
MEIP vs TOMZ Comparison
Compare MEIP & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEIP
- TOMZ
- Stock Information
- Founded
- MEIP 2000
- TOMZ 1979
- Country
- MEIP United States
- TOMZ United States
- Employees
- MEIP 28
- TOMZ N/A
- Industry
- MEIP Biotechnology: Pharmaceutical Preparations
- TOMZ Diversified Commercial Services
- Sector
- MEIP Health Care
- TOMZ Finance
- Exchange
- MEIP Nasdaq
- TOMZ Nasdaq
- Market Cap
- MEIP 17.3M
- TOMZ 20.2M
- IPO Year
- MEIP 2003
- TOMZ N/A
- Fundamental
- Price
- MEIP $2.60
- TOMZ $0.94
- Analyst Decision
- MEIP Hold
- TOMZ Strong Buy
- Analyst Count
- MEIP 2
- TOMZ 1
- Target Price
- MEIP $7.00
- TOMZ $3.50
- AVG Volume (30 Days)
- MEIP 7.5K
- TOMZ 30.6K
- Earning Date
- MEIP 02-12-2025
- TOMZ 03-31-2025
- Dividend Yield
- MEIP N/A
- TOMZ N/A
- EPS Growth
- MEIP N/A
- TOMZ N/A
- EPS
- MEIP N/A
- TOMZ N/A
- Revenue
- MEIP N/A
- TOMZ $8,197,404.00
- Revenue This Year
- MEIP N/A
- TOMZ $40.32
- Revenue Next Year
- MEIP N/A
- TOMZ $38.17
- P/E Ratio
- MEIP N/A
- TOMZ N/A
- Revenue Growth
- MEIP 33.76
- TOMZ N/A
- 52 Week Low
- MEIP $2.30
- TOMZ $0.52
- 52 Week High
- MEIP $4.42
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- MEIP 37.79
- TOMZ 45.57
- Support Level
- MEIP $2.55
- TOMZ $0.89
- Resistance Level
- MEIP $2.79
- TOMZ $1.08
- Average True Range (ATR)
- MEIP 0.14
- TOMZ 0.06
- MACD
- MEIP -0.02
- TOMZ -0.01
- Stochastic Oscillator
- MEIP 14.71
- TOMZ 26.32
About MEIP MEI Pharma Inc.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales, service and licensing of its SteraMist brand of products, including SteraMist BIT, a low percentage (7.8%) hydrogen peroxide-based fog or mist that uses Binary Ionization Technology (BIT). Its product portfolio includes SteraMist Surface Unit; SteraMist Environment System; The SteraMist Total Disinfection Cart; SteraMist Select Surface Unit; Stainless Steel 90 Degree Applicator; iHP Plasma Decontamination Chamber; SteraMist Custom Engineered System (CES); and iHP Corporate Service Decontamination.